A recent study published in the Journal of the American Medical Association have shed light on the fact that the safety issues with the biological product is much more than that of the chemical pharmaceutical drugs. The post marketing surveillance system must be tightened in all the countries where such products are used to treat patients that are suffering from chronic diseases.

1. Biological products are unsafe than the chemical products
Are you aware of the term biological products? They are a popular way of treating many grave
diseases in the lives of humans. Human blood products, plasma products are some of the
divisions in this category of the substances. Whatever may be the category that one may be
aware of the basic objective is to help in the treatment of life threatening diseases in
individuals. Human blood plasma, human blood is collected through the donations and then all
are stored to make such products which can be used for treating diseases like blood cancer,
Thalassemia, Aplastic anemia, leukemia, lymphoma, multiple myeloma, hemophilia, sepsis,
deep venous thrombosis and similar other chronic diseases. A recent study published in the
Journal of the American Medical Association have shed light on the fact that the safety issues
with the biological product is much more than that of the chemical pharmaceutical drugs. This
has led to a major discussion of concern among the top physicians all over the world.
Made from natural resources like the blood, plasma of humans, animals or micro-organisms,
they were considered to be safe for use in the treatment and cure of the life threatening
diseases. However the new fact is troubling and shocking to hear. It has been found in a recent
survey that since 1982, about two hundred and fifty biological products have got the approval
in the United States and Europe and are made available for the public in the open market.
About twenty four percent of the new drug approvals in America are made for these products.
The recent research about the complications had made things difficult for those companies
who have been using this product for their making of their drugs and medicines.

2. This is the reason why understanding both the risks and the benefits is so very essential for any
king of product that comes available in the market. The products that they will be making will
be used to save the lives of patients. However if the product has potential harmful effects, then
it can cause much harm to the person than curing the disease. The structure and composition
of the chemical substances that are used in the manufacture of the chemical dugs by the
pharmaceutical companies are known. Hence it is very easy to understand their effects and side
effects. However in the case of the biological product, this is not the case. The products have
complex structures and the components that many of the items have are not easily
recognizable. Hence they cannot be grouped under any category. Hence the safety of the
medical goods remains a big question in the medical world.
The doctors after going through the study felt that more time must be spent on the research of
such biological product so as to understand its action and reactions effectively. This will help in
tackling the potential harm that can happen with the items, if any. After the approval has been
given to the substances, it must be kept under constant surveillance so as to avoid the spread
of any side effects. The physicians in general must be now more aware that these products
pose more threat than their chemical counterparts.
The post marketing surveillance system must be tightened in all the countries where such
products are used to treat patients that are suffering from chronic diseases. This will help in
preventing all the possible side effects that can be seen while treating the patient with such
items against the life threatening diseases. Or else more patients will die from the effects of the
material than from the diseases. After all, safety matters!